Objective—To determine whether Mycoplasma haemofelis (Mhf) and Candidatus Mycoplasma haemominutum (Mhm) can be transmitted by ingestion of Mycoplasma-infected Ctenocephalides felis and by-products (feces, larvae, and eggs).
Procedure—3 cats were carriers of Mhf, and 1 was a carrier of Mhm. Six cats had negative results of PCR assay for Mhf and Mhm DNA. A chamber containing 100 C felis was bandaged to 2 Mhf carrier cats. Five days later, fleas and by-products were analyzed for Mycoplasma spp DNA. The remaining fleas and a sample of by-products were fed to 2 Mycoplasma-naïve cats. A chamber containing 200 C felis was bandaged to the Mhm carrier cat. Five days later, fleas and by-products were analyzed for Mycoplasma spp DNA. The remaining fleas and a sample of by-products were fed to 2 Mycoplasma-naïve cats. A chamber containing 200 C felis was bandaged to an Mhf carrier cat and Mhm-carrier cat. Three days later, fleas and by-products were analyzed for Mycoplasma spp DNA. The remaining fleas and a random sample of by products were fed to 4 Mycoplasma-naïve cats. All cats were monitored for infection for ≥7 weeks.
Results—Uptake of Mhf and Mhm DNA into fleas and by-products was detected. None of the naïve cats became infected.
Conclusions and Clinical Relevance—Results suggested that ingestion of Mycoplasma-infected C felis or by-products is not an important means of transmission for Mhf or Mhm.
Objective—To determine whether Ctenocephalides
felis can transmit Mycoplasma haemofelis (Mhf) and
Candidatus Mycoplasma haemominutum (Mhm)
through hematophagous activity between cats.
Procedure—2 cats were carriers of either Mhf or
Mhm. Nine cats had negative results via polymerase
chain reaction (PCR) assay for Mhf and Mhm DNA; 3
of those cats were infected from the chronic carriers
via IV inoculation of blood. At the time of maximum
organism count for each of the Mycoplasma spp, 1
chamber containing 100 C felis was bandaged to the
amplifier cats. Five days later, fleas, feces, larvae, or
eggs from each chamber were analyzed for
Mycoplasma spp DNA. Viable fleas from the chambers
were allocated into new chambers (3 Mhm and
6 Mhf) and attached to naïve cats for 5 days. Cats
were monitored daily for clinical signs and weekly via
CBC and PCR assay for infection with Mhf or Mhm for
a minimum of 8 weeks.
Results—Uptake of Mhf and Mhm DNA into fleas,
feces, and, potentially, eggs and larvae was detected.
Of the naïve cats fed on by Mhf-infected fleas, 1 cat
transiently yielded positive PCR assay results for Mhf
on 1 sampling date without clinical or hematologic
changes consistent with Mhf infection.
Conclusions and Clinical Relevance—Results suggest
that hematophagous transfer of Mhm and Mhf
into fleas occurred and that C felis is a possible vector
for Mhf via hematophagous activity. (Am J Vet Res 2005;66:1008–1012)
Objective—To identify biomarker proteins for B-cell lymphoma in canine serum by use of surface-enhanced laser desorption-ionization time-of-flight (SELDI-TOF) mass spectrometry and build classification trees with multiple biomarkers that have high sensitivity and specificity for that tumor type.
Sample Population—Sera from 29 dogs with B-cell lymphoma and 87 control dogs (approx equal numbers of healthy dogs, dogs with malignant cancers other than B-cell lymphoma, and dogs with various nonneoplastic diseases or conditions).
Procedures—Serum samples were fractionated chromatographically and analyzed via SELDI-TOF mass spectrometry. Peak amplitudes of the spectra from the 2 sample groups were compared to identify potential biomarker peaks, and classification trees were built by use of computer software to detect patterns formed by multiple biomarkers among SELDI data sets.
Results—Several biomarker protein peaks in canine serum were identified, and a classification tree was built on the basis of 3 biomarker protein peaks. With 10-fold cross-validation of the sample set, the best individual serum biomarker peak had 75% sensitivity and 86% specificity and the classification tree had 97% sensitivity and 91% specificity for the classification of B-cell lymphoma.
Conclusions and Clinical Relevance—On the basis of biomarker proteins identified in canine serum, classification trees were constructed, which may be useful for the development of a diagnostic test for B-cell lymphoma in dogs. Further investigation is needed to determine whether these biomarkers are useful for screening susceptible dog populations or for monitoring disease status during treatment and remission of B-cell lymphoma in dogs.